Australia markets close in 6 minutes
  • ALL ORDS

    7,355.30
    -2.40 (-0.03%)
     
  • ASX 200

    7,110.80
    -2.00 (-0.03%)
     
  • AUD/USD

    0.6909
    -0.0006 (-0.09%)
     
  • OIL

    89.98
    -0.52 (-0.57%)
     
  • GOLD

    1,768.80
    -2.40 (-0.14%)
     
  • BTC-AUD

    33,021.92
    -1,111.98 (-3.26%)
     
  • CMC Crypto 200

    542.33
    -15.40 (-2.76%)
     
  • AUD/EUR

    0.6853
    +0.0007 (+0.10%)
     
  • AUD/NZD

    1.1080
    +0.0036 (+0.33%)
     
  • NZX 50

    11,684.81
    -129.53 (-1.10%)
     
  • NASDAQ

    13,505.99
    +35.13 (+0.26%)
     
  • FTSE

    7,541.85
    +26.10 (+0.35%)
     
  • Dow Jones

    33,999.04
    +18.72 (+0.06%)
     
  • DAX

    13,697.41
    +70.70 (+0.52%)
     
  • Hang Seng

    19,807.36
    +43.45 (+0.22%)
     
  • NIKKEI 225

    28,918.05
    -24.09 (-0.08%)
     

2 of the Safest Stocks to Buy in a Recession

·4-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Shares of AbbVie (NYSE: ABBV) are up by about 13% this year, which is a lot better than the benchmark S&P 500 index, which has lost 20% over the same period. With lots of high-margin revenue from top-selling drugs, there's a good chance that AbbVie stock will remain a safe haven even if the U.S. economy plunges into a deep recession. The top-selling drug for AbbVie is Humira.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting